The incidence and impact of comorbidity diagnosed after the onset of head and neck cancer

Archives of Otolaryngology - Head and Neck Surgery

Volumn 134, Issue 10, 2008, Pages 1045-1049

  Yung, Katherine C ^a   Piccirillo, Jay F ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALCOHOL ABUSE; ANGINA PECTORIS; ARTICLE; CANCER DIAGNOSIS; CANCER SURVIVAL; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; FEMALE; HEAD AND NECK CANCER; HEART INFARCTION; HUMAN; HYPERTENSION; INCIDENCE; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MOUTH CARCINOMA; MULTIMODALITY CANCER THERAPY; OROPHARYNX CANCER; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SCORING SYSTEM; SOLID TUMOR;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COHORT STUDIES; COMBINED MODALITY THERAPY; COMORBIDITY; CONFIDENCE INTERVALS; DIABETES MELLITUS; DISEASE-FREE SURVIVAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM STAGING; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX DISTRIBUTION; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 54349129301     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archotol.134.10.1045     Document Type: Article

References (20)

1. Piccirillo JF, Feinstein AR. Clinical symptoms and comorbidity: significance for the prognostic classification of cancer. Cancer. 1996;77(5):834-842.
2. Satariano WA. Comorbidities and cancer. In: Hunter CP, Johnson KA, Muss HB, eds. Cancer in the Elderly. New York, NY: Marcel Dekker; 2000:477-499.
3. Yancik R, Wesley MN, Ries LA, Havlik RJ, Edwards BK, Yates JW. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA. 2001;285(7):885-892.
4. Piccirillo JF. Importance of comorbidity in head and neck cancer. Laryngoscope. 2000;110(4):593-602.
5. Singh B, Bhaya M, Zimbler M, et al. Impact of comorbidity on outcome of young patients with head and neck squamous cell carcinoma. Head Neck. 1998;20(1):1-7.
6. Sabin SL, Rosenfeld RM, Sundaram K, Har-El G, Lucente FE. The impact of comorbidity and age on survival with laryngeal cancer. Ear Nose Throat J. 1999;78(8):578, 581-584.
7. Feinstein AR, Schimpff CR, Andrews JF Jr, Wells CK. Cancer of the larynx: a new staging system and a re-appraisal of prognosis and treatment. J Chronic Dis. 1977;30(5):277-305.
8. Feinstein AR. Symptomatic patterns, biologic behavior, and prognosis in cancer of the lung: practical application of Boolean algebra and clinical taxonomy. Ann Intern Med. 1964;61(1):27-43.
9. Charlson ME, Feinstein AR. The auxometric dimension: a new method for using rate of growth in prognostic staging of breast cancer. JAMA. 1974;228(2):180-185.
10. Charlson ME, Feinstein AR. A new clinical index of growth rate in the staging of breast cancer. Am J Med. 1980;69(4):527-536.
11. Feinstein AR, Schimpff CR, Hull EW. A reappraisal of staging and therapy for patients with cancer of the rectum, I: development of two new systems of staging. Arch Intern Med. 1975;135(11):1441-1453.
12. Feinstein AR, Schimpff CR, Hull EW. A reappraisal of staging and therapy for patients with cancer of the rectum, II: patterns of presentation and outcome of treatment. Arch Intern Med. 1975;135(11):1454-1462.
13. Boyd NF, Feinstein AR. Symptoms as an index of growth rates and prognosis in Hodgkin's disease. Clin Invest Med. 1978;1(1):25-31.
14. Boyd NF, Clemens JD, Feinstein AR. Pretherapeutic morbidity in the prognostic staging of acute leukemia. Arch Intern Med. 1979;139(3):324-328.
15. Piccirillo JF, Tierney RM, Costas I, Grove L, Spitznagel EL Jr. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA. 2004;291(20):2441-2447.
16. Reid BC, Alberg AJ, Klassen AC, et al. Comorbidity and survival of elderly head and neck carcinoma patients. Cancer. 2001;92(8):2109-2116.
17. Piccirillo JF, Costas I, Claybour P, Borah AJ, Grove L, Jeffe D. The measurement of comorbidity by cancer registries. J Registry Manage. 2003;30(1):8-14.
18. Read WL, Tierney RM, Page NC, et al. Differential prognostic impact of comorbidity. J Clin Oncol. 2004;22(15):3099-3103.
19. Yancik R, Ganz PA, Varricchio CG, Conley B. Perspectives on comorbidity and cancer in older patients: approaches to expand the knowledge base. J Clin Oncol. 2001;19(4):1147-1151.
20. Piccirillo J. The impact of comorbidity in head and neck cancer. J Registry Manage. 2001;28(4):172-176.